|
Insurance & Litigation
•
|
Tools & Information
•
•
•
|
|
 Back to Eurekalert Medical and Health News Archives
Eurekalert Medical and Health News: 10-27-2004
The National Institutes of Health (NIH) reported today that it has awarded student loan repayment contracts to more than 1,400 health researchers across the nation in Fiscal Year 2004.
Yale has received a $1.7 million grant to study whether a history of use of ecstasy and marijuana is associated with cognitive deficits in adolescents.
According to current epidemiological data, approximately 1 in 200 young people suffer from obsessive-compulsive disorder (OCD). OCD can cripple their lives, disrupt their learning, and drive a wedge through their families. University of Pennsylvania School of Medicine researchers, and a team of researchers from Duke University Medical Center, have developed a scientifically conclusive treatment combination - using Cognitive Behavior Therapy and commonly prescribed anti-depressant medication - to help pediatric patients overcome OCD.
Clemson University has received a $600,000 grant from the National Science Foundation Partnerships for Innovation program. The program creates prospects for economic growth and new jobs by supporting the research-business-government relationships that transfer advances in labs to advances in lives.
Rekindling a debate on the safety of performing an increasingly popular non-surgical heart procedure in hospitals that do not have onsite cardiac surgery programs, a study led by Dartmouth Medical School (DMS) concluded that patients who undergo the procedure in hospitals without cardiac surgeons have a higher rate of mortality than those in hospitals with a cardiac surgery program.
New phosphate binder effectively lowers damaging phosphate levels in ESRD patients without the long-term safety problems of traditional options.
Novartis Pharma AG announced today that Emselex. (darifenacin hydrobromide), 7.5 mg and 15 mg, has been granted Marketing Authorization by the European Commission for the treatment of overactive bladder (OAB) in all 25 European member states as well as Norway and Iceland.
Paratek Pharmaceuticals is announcing a breakthrough in research for multiple sclerosis (MS) - the development of a new class of compounds, termed non-antibacterial tetracyclines, which have demonstrated promising activity against the best preclinical model of the disease, the EAE model (Experimental Autoimmune Encephalomyelitis). For the first time, Paratek and its partner Serono are presenting data at the Society for Neuroscience annual meeting that show that these non-antibacterial tetracycline compounds have preclinical efficacy comparable to minocycline.
Living on a cruise ship is a feasible and cost-effective option to assisted living facilities, and the services offered on a cruise ship parallel -- even surpass -- what is provided in senior care facilities, according to a study in the November issue of the Journal of the American Geriatric Society.
New research is speeding the development of brain-controlled devices that may soon allow amputees and paraplegics to use their limbs. Within a few short years, these so-called brain-computer interfaces (BCI) may also allow people completely paralyzed by neurodegenerative diseases to regain some movement or ability to communicate with those around them. The new research was presented at the 34th Society for Neuroscience annual meeting in San Diego.
Novel methods for transplanting cells into areas damaged by spinal cord injury and experimental drug treatments show promise for aiding those suffering from injury to their spinal cord. The new research was presented at the 34th Society for Neuroscience annual meeting in San Diego.
No longer a pipe dream, new animal research now indicates that marijuana-like compounds can aid a bevy of debilitating conditions, ranging from brain disorders such as amyotrophic lateral sclerosis (ALS) and Parkinson's disease, to pain and obesity. The new research was presented at the 34th Society for Neuroscience annual meeting in San Diego.
New hormone therapy studies demonstrate estrogen's ability to directly stimulate neurons, repair damaged neurons, and stimulate support cells--most of which can alleviate some of the cognitive decline associated with menopause. Other studies examine the value of cyclical versus continuous hormone administration. The new research was presented at the 34th Society for Neuroscience annual meeting in San Diego.
In September 2001, researchers at Summa Health System in Akron, Ohio reported that moderate doses of the vitamins C and K3 were eliminating many types of cancer cells including prostate, bladder, renal and ovarian. Today, only three years later, the results of Summa's cancer research is being licensed and under a new name, ApatoneTM. Clinical trials of the drug could begin as soon as next month at Summa Health System and other hospitals across the nation.
Scientists at the University of Arizona in Tucson are trying to determine what goes on inside the brain when it sees a face. How does the brain recognize faces and retrieve the names to go with them? How does the brain determine whether the information that it has retrieved is accurate?
Scientists have designed a new molecular tool, dubbed "LigAmp," to pinpoint DNA mutations among thousands of cells, the equivalent of searching for a single typo in an entire library of books. Preliminary studies in a small number of cell lines and body fluids show the ultra-sensitive test may help detect microscopic cancer and HIV drug resistance.
Research is racing to help healthcare professionals further understand how periodontal diseases are linked to cardiovascular disease. A study published in a recent issue of the Journal of Periodontology explains another reason why people with periodontal diseases are at a significant risk factor for coronary artery disease (CAD).
New clinical research on skin sterol testing was presented yesterday at the Canadian Cardiovascular Congress. The release highlights findings from the studies.
While promoting physical activity and encouraging people to limit the time they spend watching television are important throughout life, those efforts are critical before adolescence, a new University of North Carolina at Chapel Hill investigation concludes.
George W. Bush and John Kerry, along with many other politicians, have said they're for the importation of less-expensive pharmaceuticals from Canada, but according to a Penn State business law researcher, legal barriers may prevent government-run plans from ever working without industry cooperation.
Biomedical engineers and physicians at Vanderbilt University have brought the day when artificial limbs will be controlled directly by the brain considerably closer by discovering a method that uses laser light, rather than electricity, to stimulate and control nerve cells.The researchers have discovered that low-intensity infrared laser light can spark specific nerves to life, exciting a leg or even individual toes without actually touching the nerve cells.
A physician at H. Lee Moffitt Cancer Center & Research Institute at the University of South Florida received a first-place international award for his lecture on individualized treatment for patients with advanced stage ovarian cancer.
Microbial processes ultimately determine whether arsenic builds to dangerous levels in groundwater, say researchers at the University of Illinois at Urbana-Champaign. Remediation may be as simple as stimulating certain microbes to grow.
The American Society of Plant Biologists (ASPB) sent a letter today to Steve Kinsey, President of the Marin County Board of Supervisors, urging defeat of local Ballot Measure B. If passed, Measure B would prohibit growing genetically modified crops.
In the first-ever comprehensive analysis of its kind, a new Emory University study maps how brain size changed in dolphins and their relatives the past 47 million years, and helps to provide some answers to how the species evolved in relation to humans.
|
|
